Genzyme's CSR Dilemma: How to Play Its Hand, Video SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
Strategy & Execution
Strategy / MBA Resources
Case Study SWOT Analysis Solution
Case Study Description of Genzyme's CSR Dilemma: How to Play Its Hand, Video
This case highlights the conflicts and concerns in implementing corporate responsibility programs from the perspective of a global biotechnology company.
Authors :: Tarun Khanna, Christopher A. Bartlett
Topics :: Strategy & Execution
Tags :: Public relations, Social responsibility, SWOT Analysis, SWOT Matrix, TOWS, Weighted SWOT Analysis
Swot Analysis of "Genzyme's CSR Dilemma: How to Play Its Hand, Video" written by Tarun Khanna, Christopher A. Bartlett includes – strengths weakness that are internal strategic factors of the organization, and opportunities and threats that Genzyme's Csr facing as an external strategic factors. Some of the topics covered in Genzyme's CSR Dilemma: How to Play Its Hand, Video case study are - Strategic Management Strategies, Public relations, Social responsibility and Strategy & Execution.
Some of the macro environment factors that can be used to understand the Genzyme's CSR Dilemma: How to Play Its Hand, Video casestudy better are - – there is increasing trade war between United States & China, there is backlash against globalization, increasing household debt because of falling income levels, increasing government debt because of Covid-19 spendings, challanges to central banks by blockchain based private currencies, technology disruption, customer relationship management is fast transforming because of increasing concerns over data privacy,
increasing commodity prices, supply chains are disrupted by pandemic , etc
Introduction to SWOT Analysis of Genzyme's CSR Dilemma: How to Play Its Hand, Video
SWOT stands for an organization’s Strengths, Weaknesses, Opportunities and Threats . At Oak Spring University , we believe that protagonist in Genzyme's CSR Dilemma: How to Play Its Hand, Video case study can use SWOT analysis as a strategic management tool to assess the current internal strengths and weaknesses of the Genzyme's Csr, and to figure out the opportunities and threats in the macro environment – technological, environmental, political, economic, social, demographic, etc in which Genzyme's Csr operates in.
According to Harvard Business Review, 75% of the managers use SWOT analysis for various purposes such as – evaluating current scenario, strategic planning, new venture feasibility, personal growth goals, new market entry, Go To market strategies, portfolio management and strategic trade-off assessment, organizational restructuring, etc.
SWOT Objectives / Importance of SWOT Analysis and SWOT Matrix
SWOT analysis of Genzyme's CSR Dilemma: How to Play Its Hand, Video can be done for the following purposes –
1. Strategic planning using facts provided in Genzyme's CSR Dilemma: How to Play Its Hand, Video case study
2. Improving business portfolio management of Genzyme's Csr
3. Assessing feasibility of the new initiative in Strategy & Execution field.
4. Making a Strategy & Execution topic specific business decision
5. Set goals for the organization
6. Organizational restructuring of Genzyme's Csr
Strengths Genzyme's CSR Dilemma: How to Play Its Hand, Video | Internal Strategic Factors
What are Strengths in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The strengths of Genzyme's Csr in Genzyme's CSR Dilemma: How to Play Its Hand, Video Harvard Business Review case study are -
Analytics focus
– Genzyme's Csr is putting a lot of focus on utilizing the power of analytics in business decision making. This has put it among the leading players in the industry. The technology infrastructure suggested by Tarun Khanna, Christopher A. Bartlett can also help it to harness the power of analytics for – marketing optimization, demand forecasting, customer relationship management, inventory management, information sharing across the value chain etc.
Operational resilience
– The operational resilience strategy in the Genzyme's CSR Dilemma: How to Play Its Hand, Video Harvard Business Review case study comprises – understanding the underlying the factors in the industry, building diversified operations across different geographies so that disruption in one part of the world doesn’t impact the overall performance of the firm, and integrating the various business operations and processes through its digital transformation drive.
Ability to recruit top talent
– Genzyme's Csr is one of the leading recruiters in the industry. Managers in the Genzyme's CSR Dilemma: How to Play Its Hand, Video are in a position to attract the best talent available. The firm has a robust talent identification program that helps in identifying the brightest.
Strong track record of project management
– Genzyme's Csr is known for sticking to its project targets. This enables the firm to manage – time, project costs, and have sustainable margins on the projects.
Organizational Resilience of Genzyme's Csr
– The covid-19 pandemic has put organizational resilience at the centre of everthing that Genzyme's Csr does. Organizational resilience comprises - Financial Resilience, Operational Resilience, Technological Resilience, Organizational Resilience, Business Model Resilience, and Reputation Resilience.
Innovation driven organization
– Genzyme's Csr is one of the most innovative firm in sector. Manager in Genzyme's CSR Dilemma: How to Play Its Hand, Video Harvard Business Review case study can use Clayton Christensen Disruptive Innovation strategies to further increase the scale of innovtions in the organization.
Sustainable margins compare to other players in Strategy & Execution industry
– Genzyme's CSR Dilemma: How to Play Its Hand, Video firm has clearly differentiated products in the market place. This has enabled Genzyme's Csr to fetch slight price premium compare to the competitors in the Strategy & Execution industry. The sustainable margins have also helped Genzyme's Csr to invest into research and development (R&D) and innovation.
Low bargaining power of suppliers
– Suppliers of Genzyme's Csr in the sector have low bargaining power. Genzyme's CSR Dilemma: How to Play Its Hand, Video has further diversified its suppliers portfolio by building a robust supply chain across various countries. This helps Genzyme's Csr to manage not only supply disruptions but also source products at highly competitive prices.
Effective Research and Development (R&D)
– Genzyme's Csr has innovation driven culture where significant part of the revenues are spent on the research and development activities. This has resulted in, as mentioned in case study Genzyme's CSR Dilemma: How to Play Its Hand, Video - staying ahead in the industry in terms of – new product launches, superior customer experience, highly competitive pricing strategies, and great returns to the shareholders.
Superior customer experience
– The customer experience strategy of Genzyme's Csr in the segment is based on four key concepts – personalization, simplification of complex needs, prompt response, and continuous engagement.
Training and development
– Genzyme's Csr has one of the best training and development program in the industry. The effectiveness of the training programs can be measured in Genzyme's CSR Dilemma: How to Play Its Hand, Video Harvard Business Review case study by analyzing – employees retention, in-house promotion, loyalty, new venture initiation, lack of conflict, and high level of both employees and customer engagement.
Successful track record of launching new products
– Genzyme's Csr has launched numerous new products in last few years, keeping in mind evolving customer preferences and competitive pressures. Genzyme's Csr has effective processes in place that helps in exploring new product needs, doing quick pilot testing, and then launching the products quickly using its extensive distribution network.
Weaknesses Genzyme's CSR Dilemma: How to Play Its Hand, Video | Internal Strategic Factors
What are Weaknesses in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The weaknesses of Genzyme's CSR Dilemma: How to Play Its Hand, Video are -
No frontier risks strategy
– After analyzing the HBR case study Genzyme's CSR Dilemma: How to Play Its Hand, Video, it seems that company is thinking about the frontier risks that can impact Strategy & Execution strategy. But it has very little resources allocation to manage the risks emerging from events such as natural disasters, climate change, melting of permafrost, tacking the rise of artificial intelligence, opportunities and threats emerging from commercialization of space etc.
Skills based hiring
– The stress on hiring functional specialists at Genzyme's Csr has created an environment where the organization is dominated by functional specialists rather than management generalist. This has resulted into product oriented approach rather than marketing oriented approach or consumers oriented approach.
Increasing silos among functional specialists
– The organizational structure of Genzyme's Csr is dominated by functional specialists. It is not different from other players in the Strategy & Execution segment. Genzyme's Csr needs to de-silo the office environment to harness the true potential of its workforce. Secondly the de-silo will also help Genzyme's Csr to focus more on services rather than just following the product oriented approach.
Compensation and incentives
– The revenue per employee as mentioned in the HBR case study Genzyme's CSR Dilemma: How to Play Its Hand, Video, is just above the industry average. Genzyme's Csr needs to redesign the compensation structure and incentives to increase the revenue per employees. Some of the steps that it can take are – hiring more specialists on project basis, etc.
High dependence on star products
– The top 2 products and services of the firm as mentioned in the Genzyme's CSR Dilemma: How to Play Its Hand, Video HBR case study still accounts for major business revenue. This dependence on star products in has resulted into insufficient focus on developing new products, even though Genzyme's Csr has relatively successful track record of launching new products.
High bargaining power of channel partners
– Because of the regulatory requirements, Tarun Khanna, Christopher A. Bartlett suggests that, Genzyme's Csr is facing high bargaining power of the channel partners. So far it has not able to streamline the operations to reduce the bargaining power of the value chain partners in the industry.
Lack of clear differentiation of Genzyme's Csr products
– To increase the profitability and margins on the products, Genzyme's Csr needs to provide more differentiated products than what it is currently offering in the marketplace.
Ability to respond to the competition
– As the decision making is very deliberative, highlighted in the case study Genzyme's CSR Dilemma: How to Play Its Hand, Video, in the dynamic environment Genzyme's Csr has struggled to respond to the nimble upstart competition. Genzyme's Csr has reasonably good record with similar level competitors but it has struggled with new entrants taking away niches of its business.
Need for greater diversity
– Genzyme's Csr has taken concrete steps on diversity, equity, and inclusion. But the efforts so far has resulted in limited success. It needs to expand the recruitment and selection process to hire more people from the minorities and underprivileged background.
Low market penetration in new markets
– Outside its home market of Genzyme's Csr, firm in the HBR case study Genzyme's CSR Dilemma: How to Play Its Hand, Video needs to spend more promotional, marketing, and advertising efforts to penetrate international markets.
Products dominated business model
– Even though Genzyme's Csr has some of the most successful products in the industry, this business model has made each new product launch extremely critical for continuous financial growth of the organization. firm in the HBR case study - Genzyme's CSR Dilemma: How to Play Its Hand, Video should strive to include more intangible value offerings along with its core products and services.
Opportunities Genzyme's CSR Dilemma: How to Play Its Hand, Video | External Strategic Factors
What are Opportunities in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The opportunities highlighted in the Harvard Business Review case study Genzyme's CSR Dilemma: How to Play Its Hand, Video are -
Leveraging digital technologies
– Genzyme's Csr can leverage digital technologies such as artificial intelligence and machine learning to automate the production process, customer analytics to get better insights into consumer behavior, realtime digital dashboards to get better sales tracking, logistics and transportation, product tracking, etc.
Increase in government spending
– As the United States and other governments are increasing social spending and infrastructure spending to build economies post Covid-19, Genzyme's Csr can use these opportunities to build new business models that can help the communities that Genzyme's Csr operates in. Secondly it can use opportunities from government spending in Strategy & Execution sector.
Developing new processes and practices
– Genzyme's Csr can develop new processes and procedures in Strategy & Execution industry using technology such as automation using artificial intelligence, real time transportation and products tracking, 3D modeling for concept development and new products pilot testing etc.
Lowering marketing communication costs
– 5G expansion will open new opportunities for Genzyme's Csr in the field of marketing communication. It will bring down the cost of doing business, provide technology platform to build new products in the Strategy & Execution segment, and it will provide faster access to the consumers.
Using analytics as competitive advantage
– Genzyme's Csr has spent a significant amount of money and effort to integrate analytics and machine learning into its operations in the sector. This continuous investment in analytics has enabled, as illustrated in the Harvard case study Genzyme's CSR Dilemma: How to Play Its Hand, Video - to build a competitive advantage using analytics. The analytics driven competitive advantage can help Genzyme's Csr to build faster Go To Market strategies, better consumer insights, developing relevant product features, and building a highly efficient supply chain.
Reconfiguring business model
– The expansion of digital payment system, the bringing down of international transactions costs using Bitcoin and other blockchain based currencies, etc can help Genzyme's Csr to reconfigure its entire business model. For example it can used blockchain based technologies to reduce piracy of its products in the big markets such as China. Secondly it can use the popularity of e-commerce in various developing markets to build a Direct to Customer business model rather than the current Channel Heavy distribution network.
Loyalty marketing
– Genzyme's Csr has focused on building a highly responsive customer relationship management platform. This platform is built on in-house data and driven by analytics and artificial intelligence. The customer analytics can help the organization to fine tune its loyalty marketing efforts, increase the wallet share of the organization, reduce wastage on mainstream advertising spending, build better pricing strategies using personalization, etc.
Reforming the budgeting process
- By establishing new metrics that will be used to evaluate both existing and potential projects Genzyme's Csr can not only reduce the costs of the project but also help it in integrating the projects with other processes within the organization.
Finding new ways to collaborate
– Covid-19 has not only transformed business models of companies in Strategy & Execution industry, but it has also influenced the consumer preferences. Genzyme's Csr can tie-up with other value chain partners to explore new opportunities regarding meeting customer demands and building a rewarding and engaging relationship.
Buying journey improvements
– Genzyme's Csr can improve the customer journey of consumers in the industry by using analytics and artificial intelligence. Genzyme's CSR Dilemma: How to Play Its Hand, Video suggest that firm can provide automated chats to help consumers solve their own problems, provide online suggestions to get maximum out of the products and services, and help consumers to build a community where they can interact with each other to develop new features and uses.
Remote work and new talent hiring opportunities
– The widespread usage of remote working technologies during Covid-19 has opened opportunities for Genzyme's Csr to expand its talent hiring zone. According to McKinsey Global Institute, 20% of the high end workforce in fields such as finance, information technology, can continously work from remote local post Covid-19. This presents a really great opportunity for Genzyme's Csr to hire the very best people irrespective of their geographical location.
Creating value in data economy
– The success of analytics program of Genzyme's Csr has opened avenues for new revenue streams for the organization in the industry. This can help Genzyme's Csr to build a more holistic ecosystem as suggested in the Genzyme's CSR Dilemma: How to Play Its Hand, Video case study. Genzyme's Csr can build new products and services such as - data insight services, data privacy related products, data based consulting services, etc.
Better consumer reach
– The expansion of the 5G network will help Genzyme's Csr to increase its market reach. Genzyme's Csr will be able to reach out to new customers. Secondly 5G will also provide technology framework to build new tools and products that can help more immersive consumer experience and faster consumer journey.
Threats Genzyme's CSR Dilemma: How to Play Its Hand, Video External Strategic Factors
What are Threats in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The threats mentioned in the HBR case study Genzyme's CSR Dilemma: How to Play Its Hand, Video are -
Stagnating economy with rate increase
– Genzyme's Csr can face lack of demand in the market place because of Fed actions to reduce inflation. This can lead to sluggish growth in the economy, lower demands, lower investments, higher borrowing costs, and consolidation in the field.
Environmental challenges
– Genzyme's Csr needs to have a robust strategy against the disruptions arising from climate change and energy requirements. EU has identified it as key priority area and spending 30% of its 880 billion Euros European post Covid-19 recovery funds on green technology. Genzyme's Csr can take advantage of this fund but it will also bring new competitors in the Strategy & Execution industry.
New competition
– After the dotcom bust of 2001, financial crisis of 2008-09, the business formation in US economy had declined. But in 2020 alone, there are more than 1.5 million new business applications in United States. This can lead to greater competition for Genzyme's Csr in the Strategy & Execution sector and impact the bottomline of the organization.
Increasing wage structure of Genzyme's Csr
– Post Covid-19 there is a sharp increase in the wages especially in the jobs that require interaction with people. The increasing wages can put downward pressure on the margins of Genzyme's Csr.
Capital market disruption
– During the Covid-19, Dow Jones has touched record high. The valuations of a number of companies are way beyond their existing business model potential. This can lead to capital market correction which can put a number of suppliers, collaborators, value chain partners in great financial difficulty. It will directly impact the business of Genzyme's Csr.
High level of anxiety and lack of motivation
– the Great Resignation in United States is the sign of broader dissatisfaction among the workforce in United States. Genzyme's Csr needs to understand the core reasons impacting the Strategy & Execution industry. This will help it in building a better workplace.
Trade war between China and United States
– The trade war between two of the biggest economies can hugely impact the opportunities for Genzyme's Csr in the Strategy & Execution industry. The Strategy & Execution industry is already at various protected from local competition in China, with the rise of trade war the protection levels may go up. This presents a clear threat of current business model in Chinese market.
Instability in the European markets
– European Union markets are facing three big challenges post Covid – expanded balance sheets, Brexit related business disruption, and aggressive Russia looking to distract the existing security mechanism. Genzyme's Csr will face different problems in different parts of Europe. For example it will face inflationary pressures in UK, France, and Germany, balance sheet expansion and demand challenges in Southern European countries, and geopolitical instability in the Eastern Europe.
Technology acceleration in Forth Industrial Revolution
– Genzyme's Csr has witnessed rapid integration of technology during Covid-19 in the Strategy & Execution industry. As one of the leading players in the industry, Genzyme's Csr needs to keep up with the evolution of technology in the Strategy & Execution sector. According to Mckinsey study top managers believe that the adoption of technology in operations, communications is 20-25 times faster than what they planned in the beginning of 2019.
Consumer confidence and its impact on Genzyme's Csr demand
– There is a high probability of declining consumer confidence, given – high inflammation rate, rise of gig economy, lower job stability, increasing cost of living, higher interest rates, and aging demography. All the factors contribute to people saving higher rate of their income, resulting in lower consumer demand in the industry and other sectors.
Learning curve for new practices
– As the technology based on artificial intelligence and machine learning platform is getting complex, as highlighted in case study Genzyme's CSR Dilemma: How to Play Its Hand, Video, Genzyme's Csr may face longer learning curve for training and development of existing employees. This can open space for more nimble competitors in the field of Strategy & Execution .
Backlash against dominant players
– US Congress and other legislative arms of the government are getting tough on big business especially technology companies. The digital arm of Genzyme's Csr business can come under increasing regulations regarding data privacy, data security, etc.
Regulatory challenges
– Genzyme's Csr needs to prepare for regulatory challenges as consumer protection groups and other pressure groups are vigorously advocating for more regulations on big business - to reduce inequality, to create a level playing field, to product data privacy and consumer privacy, to reduce the influence of big money on democratic institutions, etc. This can lead to significant changes in the Strategy & Execution industry regulations.
Weighted SWOT Analysis of Genzyme's CSR Dilemma: How to Play Its Hand, Video Template, Example
Not all factors mentioned under the Strengths, Weakness, Opportunities, and Threats quadrants in the SWOT Analysis are equal. Managers in the HBR case study Genzyme's CSR Dilemma: How to Play Its Hand, Video needs to zero down on the relative importance of each factor mentioned in the Strengths, Weakness, Opportunities, and Threats quadrants.
We can provide the relative importance to each factor by assigning relative weights. Weighted SWOT analysis process is a three stage process –
First stage for doing weighted SWOT analysis of the case study Genzyme's CSR Dilemma: How to Play Its Hand, Video is to rank the strengths and weaknesses of the organization. This will help you to assess the most important strengths and weaknesses of the firm and which one of the strengths and weaknesses mentioned in the initial lists are marginal and can be left out.
Second stage for conducting weighted SWOT analysis of the Harvard case study Genzyme's CSR Dilemma: How to Play Its Hand, Video is to give probabilities to the external strategic factors thus better understanding the opportunities and threats arising out of macro environment changes and developments.
Third stage of constructing weighted SWOT analysis of Genzyme's CSR Dilemma: How to Play Its Hand, Video is to provide strategic recommendations includes – joining likelihood of external strategic factors such as opportunities and threats to the internal strategic factors – strengths and weaknesses. You should start with external factors as they will provide the direction of the overall industry. Secondly by joining probabilities with internal strategic factors can help the company not only strategic fit but also the most probably strategic trade-off that Genzyme's Csr needs to make to build a sustainable competitive advantage.
